Key result
COVID-19 infection is linked to diverse cardiovascular complications spanning myocardial injury, heart failure, and thrombosis.
Why the study?
Cardiovascular complications including pulmonary arterial hypertension following COVID-19 infection require evaluation and awareness in clinical management.
May prompt cardiac monitoring in COVID-19; leaves open need for prospective data on incidence and interventions.
Acute myocardial infarction Heart failure Myocarditis TroponinBackground: The coronavirus disease of 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).While systemic inflammation and pulmonary complications can result in significant morbidity and mortality, cardiovascular complications may also occur.Objective: This brief report evaluates cardiovascular complications in the setting of COVID-19 infection.Discussion: The current COVID-19 pandemic has resulted in over one million infected worldwide and thousands of death.The virus binds and enters through angiotensin-converting enzyme 2 (ACE2).COVID-19 can result in systemic inflammation, multiorgan dysfunction, and critical illness.The cardiovascular system is also affected, with complications including myocardial injury, myocarditis, acute myocardial infarction, heart failure, dysrhythmias, and venous thromboembolic events.Current therapies for COVID-19 may interact with cardiovascular medications.Conclusions: Emergency clinicians should be aware of these cardiovascular complications when evaluating and managing the patient with COVID-19.
No takes yet. Share an insight, caveat, or question.
King et al. (2023) conducted a review in COVID-19. COVID-19 infection was evaluated. COVID-19 infection is associated with multiple cardiovascular complications, including myocardial injury, myocarditis, acute myocardial infarction, heart failure, dysrhythmias, and venous thromboembolic events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: